⟵ Back to Search Results

BGB-900-102

Active, not recruiting

Study of BGB-A425 and LBL-007 in Combination With Tislelizumab in Advanced Solid Tumors

Beigene Study ID info

BGB-900-102

ClinicalTrials.gov ID info

NCT03744468

EudraCT Number info

2022-500694-14

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents